Cancer Antigen 125 eCLIA is an immunoassay reagent for in vitro quantitative determination of Cancer Antigen 125 (CA125) in human serum and plasma by fully automated immunoassay analyzer to aid diagnosis of ovarian cancer and other diseases.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.